Citalopram/Lithium Carbonate

西酞普兰/碳酸锂

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCitalopram/Lithium Carbonate
Drug Alias NameCitalopram+Lithium Carbonate碳酸锂/西酞普兰Citalopram and Lithium Carbonate西酞普兰+碳酸锂西酞普兰-碳酸锂 +[10] 
ClassificationSmall molecules
Mechanisms of ActionSerotonin transporter inhibitors
TargetsSerotonin transporter
Therapy Area/IndicationsSchizotypal Personality Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Citalopram HydrobromideLithium Carbonate
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesColumbia Northwest Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesColumbia Northwest Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsSchizotypal Personality Disorder

Other Information

ATC CodeN/A
Related LinksN/A